Dominique Francon Selected Research

tetrahydro-pyran-4-carboxylic acid (2- methyl- 4- (2- methyl- (1,3')bipyrrolidinyl- 1'- yl)phenyl)amide

11/2013

Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Francon Research Topics

Disease

1	Sleep Wake Disorders 11/2013

Drug/Important Bio-Agent (IBA)

1	tetrahydro-pyran-4-carboxylic acid (2- methyl- 4- (2- methyl- (1,3')bipyrrolidinyl- 1'- yl)phenyl)amideIBA 11/2013
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 11/2013